250 related articles for article (PubMed ID: 22526766)
21. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
Umapathi T; Li Z; Verma K; Yuki N
Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
[TBL] [Abstract][Full Text] [Related]
22. Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.
Hosokawa T; Nakajima H; Unoda K; Yamane K; Doi Y; Ishida S; Kimura F; Hanafusa T
J Neurol; 2016 Sep; 263(9):1709-18. PubMed ID: 27278064
[TBL] [Abstract][Full Text] [Related]
23. Guillain-Barré syndrome: subtypes and predictors of outcome from India.
Kalita J; Misra UK; Goyal G; Das M
J Peripher Nerv Syst; 2014 Mar; 19(1):36-43. PubMed ID: 24456386
[TBL] [Abstract][Full Text] [Related]
24. Analysis of serum interleukin-27 and interleukin-35 concentrations in patients with Guillain-Barré syndrome.
Zhang LJ; Guo HY; Zhang DQ; Wang R; Li T; Li LM; Suo DM; Yang L
Clin Chim Acta; 2017 May; 468():5-9. PubMed ID: 28167198
[TBL] [Abstract][Full Text] [Related]
25. Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies.
Kmezic I; Samuelsson K; Finn A; Upate Z; Blennow K; Zetterberg H; Press R
Eur J Neurol; 2022 Sep; 29(9):2810-2822. PubMed ID: 35638376
[TBL] [Abstract][Full Text] [Related]
26. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
27. Ratio and index of Neurofilament light chain indicate its origin in Guillain-Barré Syndrome.
Körtvelyessy P; Kuhle J; Düzel E; Vielhaber S; Schmidt C; Heinius A; Leypoldt F; Schraven B; Reinhold D; Leppert D; Goihl A
Ann Clin Transl Neurol; 2020 Nov; 7(11):2213-2220. PubMed ID: 33030817
[TBL] [Abstract][Full Text] [Related]
28. Elevated levels of phosphorylated neurofilament heavy subunit in the cerebrospinal fluid of patients with lumbar spinal stenosis: preliminary findings.
Ohya J; Chikuda H; Kato S; Hayakawa K; Oka H; Takeshita K; Tanaka S; Ogata T
Spine J; 2015 Jul; 15(7):1587-92. PubMed ID: 25797810
[TBL] [Abstract][Full Text] [Related]
29. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
[TBL] [Abstract][Full Text] [Related]
30. Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study.
Axelsson M; Sjögren M; Andersen O; Blennow K; Zetterberg H; Lycke J
Acta Neurol Scand; 2018 Aug; 138(2):143-150. PubMed ID: 29624650
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological subtypes and prognosis of Guillain-Barré syndrome in northeastern China.
Ye Y; Wang K; Deng F; Xing Y
Muscle Nerve; 2013 Jan; 47(1):68-71. PubMed ID: 23042578
[TBL] [Abstract][Full Text] [Related]
32. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.
Ho TW; Willison HJ; Nachamkin I; Li CY; Veitch J; Ung H; Wang GR; Liu RC; Cornblath DR; Asbury AK; Griffin JW; McKhann GM
Ann Neurol; 1999 Feb; 45(2):168-73. PubMed ID: 9989618
[TBL] [Abstract][Full Text] [Related]
33. Increased Cerebrospinal Fluid Uric Acid Levels in Guillain-Barré Syndrome.
Chang SH; Tian XB; Wang J; Liu MQ; Huang CN; Qi Y; Zhang LJ; Gao CL; Zhang DQ; Sun LS; Yang L
Front Neurol; 2020; 11():589928. PubMed ID: 33281729
[TBL] [Abstract][Full Text] [Related]
34. Fine specificities of anti-LM1 IgG antibodies in Guillain-Barré syndrome.
Susuki K; Yuki N; Hirata K; Kuwabara S
J Neurol Sci; 2002 Mar; 195(2):145-8. PubMed ID: 11897245
[TBL] [Abstract][Full Text] [Related]
35. Cav2.1 voltage-dependent Ca2+ channel current is inhibited by serum from select patients with Guillain-Barré syndrome.
Nakatani Y; Hotta S; Utsunomiya I; Tanaka K; Hoshi K; Ariga T; Yu RK; Miyatake T; Taguchi K
Neurochem Res; 2009 Jan; 34(1):149-57. PubMed ID: 18478327
[TBL] [Abstract][Full Text] [Related]
36. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study.
Sekiguchi Y; Uncini A; Yuki N; Misawa S; Notturno F; Nasu S; Kanai K; Noto Y; Fujimaki Y; Shibuya K; Ohmori S; Sato Y; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):23-8. PubMed ID: 22010183
[TBL] [Abstract][Full Text] [Related]
37. [Follow-up study on the clinical characteristics and treatment effect of the different types of Guillain-Barré syndrome in children].
Wang XH; Zou LP; Wu HS; Fang F; Lü JL; Xiao J; Ding CH; Chen CH; Wang X; Jin H; Zhou WM; Cai FY
Zhonghua Er Ke Za Zhi; 2011 Aug; 49(8):583-8. PubMed ID: 22093419
[TBL] [Abstract][Full Text] [Related]
38. Pain in acute motor axonal neuropathy.
Zhao F; Wang J; Zhang J; Pang X; Huang S; Chang X; Guo J; Zhang W
Muscle Nerve; 2021 Dec; 64(6):739-743. PubMed ID: 34506042
[TBL] [Abstract][Full Text] [Related]
39. Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke.
Pujol-Calderón F; Portelius E; Zetterberg H; Blennow K; Rosengren LE; Höglund K
Neurosci Lett; 2019 Apr; 698():58-63. PubMed ID: 30599262
[TBL] [Abstract][Full Text] [Related]
40. Guillain-Barré syndrome in southern China: retrospective analysis of hospitalised patients from 14 provinces in the area south of the Huaihe River.
Liu S; Xiao Z; Lou M; Ji F; Shao B; Dai H; Luo C; Hu B; Zhou R; Zou Z; Li J; Li X; Xu J; Hu F; Qin C; Wang L; Liu T; Bai R; Chen Y; Lv H; Zhang R; Wang X; Wang Y; Ren S; He X; Jiang Z; Wu H; Yu D; Yang W; Luo W; Gong D; Chen B; Liu Y; Yao J; Yang Y; Guan J; Zhu M; Fu X; Gao G; Zhang H; Ding M; Fan S; Cao Q; Lu J; Lu Z
J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):618-626. PubMed ID: 29326294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
